InChI=1S/C27H28O10/c1- 11(2) 8- 18(31) 36- 26- 23(33) 25(37- 27(24(26) 34) 35- 13(4) 28) 19- 14- 6- 5- 7- 16(29) 20(14) 22(32) 21- 15(19) 9- 12(3) 10- 17(21) 30/h5- 10,19,23- 27,29- 30,33- 34H,1- 4H3/t19- ,23- ,24+,25- ,26+,27+/m0/s1 |
NVWRUTJMHZBGQX-VJXMHWMPSA-N |
[H] [C@] 1(O[C@@H] (OC(C) =O) [C@H] (O) [C@H] (OC(=O) C=C(C) C) [C@H] 1O) [C@@] 1([H] ) c2cccc(O) c2C(=O) c2c(O) cc(C) cc12 |
|
Alvaradoa haitiensis
(IPNI:10503-2)
|
Found in
leaf
(BTO:0000713).
See:
PubMed
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(5S)- 1- O- acetyl- 5- [(9S)- 4,5- dihydroxy- 2- methyl- 10- oxo- 9,10- dihydroanthracen- 9- yl]- 3- O- (3- methylbut- 2- enoyl)- α- L- lyxopyranose
|
(10S)- C- (1- O- acetyl- 3- O- senecioyl)- β- L- lyxopyranosyl- 1,8- dihydroxy- 3- methylanthracen- 9(10H)- one
Note: (2012-11-26) Note that this synonym is a misnomer; alvaradoin H is an α-L-lyxopyranose derivative. |
|
ChEBI
|
11184550
|
Reaxys Registry Number
|
Reaxys
|
17552563
|
PubMed citation
|
Europe PMC
|
|